Eli Lilly moves to defend FDA’s tirzepatide shortage resolution amid criticism over supply issues and compounding pharmacy claims.
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks ‘Swift End’ And ‘To Protect Its Interests’
Where Today's News Shapes Tomorrow
